Clinical pharmacology of monoamine oxidase inhibitors.
D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D003130:Combat Disorders / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005157:Facial Pain / Q000188:drug therapy; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy; D007024:Hypotension, Orthostatic / Q000188:drug therapy; D007700:Kinetics; D001523:Mental Disorders / Q000188:drug therapy*; D008881:Migraine Disorders / Q000188:drug therapy; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009290:Narcolepsy / Q000188:drug therapy; D009450:Neurodermatitis / Q000188:drug therapy; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010200:Panic; D010300:Parkinson Disease / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy
D008996:Monoamine Oxidase Inhibitors